Health benefits from US NIH clinical trials programme outweigh costs

EMBARGO: 00:01H (London time) Friday April 21, 2006. In North America the embargo lifts at 18:30H ET Thursday April 20, 2006.

One of the US National Institutes of Health's clinical trials programmes has had substantial returns on investment in terms of public health gains, according to an article in this week's issue of The Lancet.

Few attempts have been made to systematically evaluate whether government investment in medical research has worthwhile returns in terms of gains for public health.

S. Claiborne Johnston (University of California, San Francisco, CA, USA) and colleagues estimated the costs and benefits to society of all randomised phase III clinical trials funded by the US National Institute of Neurological Disorders and Stroke before Jan 1, 2000. 28 trials met the criteria. The total cost of these trials was US$ 335 million. The investigators assessed improvements in health and savings that resulted from the trials by reviewing publications on use, cost to society, and health effects for each intervention studied. This information was available for 8 of the 28 trials. The researchers projected the effect of the trials at 10 years and found that they led to a benefit of 470 339 quality-adjusted years (a unit equivalent to an additional year of healthy life) at a total cost of US$ 3.6 billion. The team concluded that the benefits of the research programme to society far outweighed the costs, with an overall projected net benefit of over US$15 billion at 10 years.

Dr Johnston states: "For this institute, the public return on investment in clinical trials has been substantial. Although results led to increases in health-care expenditures, health gains were large and valuable."

See also accompanying Comment by John Davidson and Colin Blakemore from the UK's Medical Research Council.


Contact: Carol Hyman Media Relations, University of California, San Francisco, CA, USA. T) 415-476-2557 [email protected]

Last reviewed: By John M. Grohol, Psy.D. on 30 Apr 2016
    Published on All rights reserved.